Polypharmacy in Older Adults with Alzheimer’s Disease

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)


The number of patients with Alzheimer’s disease is increasing annually. Most of these patients are older adults with comorbid physical illnesses, which means that they are often treated with a combination of medications for the disease they have and those for Alzheimer’s disease. Thus, older adults with Alzheimer’s disease are potentially at risk for polypharmacy. In addition, the drug interactions between Alzheimer’s disease medications and those for the treatment of physical illnesses may reduce their efficacy and increase side effects. This article reviews polypharmacy and drug interactions in elderly patients with Alzheimer’s disease, with a focus on psychotropic drugs.

Original languageEnglish
Article number1445
JournalMedicina (Lithuania)
Issue number10
Publication statusPublished - Oct 2022


  • Alzheimer’s disease
  • drug interactions
  • polypharmacy

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Polypharmacy in Older Adults with Alzheimer’s Disease'. Together they form a unique fingerprint.

Cite this